MedPath

A study to determine the efficacy of restricted fluid administration in improving health of babies who have brain injury due to less oxygen during birth.

Phase 3
Completed
Conditions
Health Condition 1: 3- AdministrationHealth Condition 2: null- Neonates with perinatal asphyxiaHealth Condition 3: P039- Newborn affected by complication of labor and delivery, unspecified
Registration Number
CTRI/2017/03/008156
Lead Sponsor
Diamond Jubilee Society Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
210
Inclusion Criteria

neonate with perinatal asphyxia

Exclusion Criteria

neonate with congenital malformation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PRIMARY OUTCOME: Neonatal mortality or severe neurodevelopmental disability at discharge. <br/ ><br>Timepoint: at discharge. <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
1)electrolyte disturbances <br/ ><br> <br/ ><br>2)Urine output1ml/kg/h during the first three days of life. <br/ ><br>3)Abnormal renal function after the first 24 hours of life as a reflection of the asphyxia insult . <br/ ><br>4)Seizures requiring anticonvulsants: detection of seizures based on either clinical grounds,detection by electroencephalogram, or by treatment of seizures with antiepilectic treatment. <br/ ><br>5) CT or MRI changes consistent with asphyxia <br/ ><br>Timepoint: electrolytes on day 1 and day 2 <br/ ><br>urine output on day 1,2 and 3 <br/ ><br>Renal function on day 2 <br/ ><br>seizures during admission(day 1-7) <br/ ><br>MRI at discharge <br/ ><br> <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath